GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDL Biotech AB (XSAT:IDL) » Definitions » FCF Yield %

IDL Biotech AB (XSAT:IDL) FCF Yield % : -5.65 (As of May. 25, 2024)


View and export this data going back to 2004. Start your Free Trial

What is IDL Biotech AB FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, IDL Biotech AB's Trailing 12-Month Free Cash Flow is kr0.00 Mil, and Market Cap is kr181.62 Mil. Therefore, IDL Biotech AB's FCF Yield % for today is -5.65%.

The historical rank and industry rank for IDL Biotech AB's FCF Yield % or its related term are showing as below:

XSAT:IDL' s FCF Yield % Range Over the Past 10 Years
Min: -5.65   Med: 0   Max: 0
Current: -5.65


XSAT:IDL's FCF Yield % is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: -3.815 vs XSAT:IDL: -5.65

IDL Biotech AB's FCF Margin % for the quarter that ended in Jun. 2021 was -12.83%.


IDL Biotech AB FCF Yield % Historical Data

The historical data trend for IDL Biotech AB's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDL Biotech AB FCF Yield % Chart

IDL Biotech AB Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.58 -0.71 -1.94 -3.65 -8.41

IDL Biotech AB Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.85 -10.85 -16.12 -8.25 -1.78

Competitive Comparison of IDL Biotech AB's FCF Yield %

For the Diagnostics & Research subindustry, IDL Biotech AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDL Biotech AB's FCF Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDL Biotech AB's FCF Yield % distribution charts can be found below:

* The bar in red indicates where IDL Biotech AB's FCF Yield % falls into.



IDL Biotech AB FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

IDL Biotech AB's FCF Yield % for the fiscal year that ended in Dec. 2020 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-8.381 / 99.635906
=-8.41%

IDL Biotech AB's annualized FCF Yield % for the quarter that ended in Jun. 2021 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.812 * 4 / 182.245423
=-1.78%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IDL Biotech AB FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


IDL Biotech AB FCF Yield % Related Terms

Thank you for viewing the detailed overview of IDL Biotech AB's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


IDL Biotech AB (XSAT:IDL) Business Description

Traded in Other Exchanges
N/A
Address
Karlsbodavagen 39, Stockholm, SWE
IDL Biotech AB develops, produces and markets In Vitro Diagnostic tests for the health care sector. It offers in vitro diagnostic tests within the clinical areas of oncology and bacteriology. The company's trademark products includes TUBEX, TPS, UBC, MonoTotal and TPAcyk.

IDL Biotech AB (XSAT:IDL) Headlines

No Headlines